Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of ...

With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster ...

Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Bayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou ...

The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...

Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...

Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...

Americans are at risk of cardiovascular disease. Bayer aspirin is on a mission to combat the high statistics of people who ...

Did you know, that in a study of those who experienced a heart attack at age 50 or younger, half were not previously seen as ...

Their relegation six-pointer against Holstein Kiel resulted in an emphatic 3-1 win that lifted them off the bottom of the table and put Holstein there in their place. Every team in the bottom three ...